All UK & Rest of Europe articles
-
NewsEvolutionary study reveals the toxic reach of disease-causing bacteria across the plant kingdom
The capacity of bacteria to spread disease across the plant kingdom may be much more widespread than previously suspected, according to a comparative evolutionary analysis, using the diversity of Pseudomonas syringae bacteria.
-
NewsThe role of understudied dysfunctional immune cells in severe COVID-19: new research
A new study focuses on understanding how ‘notoriously understudied’ immune cells behave abnormally in patients with severe COVID-19 and provides insights into mechanism behind COVID-19 disease progression.
-
NewsConnectivity loss in pond networks threatens microbial biodiversity
A recent study explored the effects of connectivity loss within pond networks, using an outdoor experimental setup of artificial ponds (mesocosms).
-
NewsPhytochromes: The ‘eyes’ that enable microalgae to find their way in the depths
By studying the light perception process of diatoms, a group of phytoplankton, scientists have discovered that these microalgae use light variation sensors which are codified in their genomes: phytochromes.
-
NewsAfter lockdown, immune system reacts more strongly to viruses and bacteria
The lockdowns during the COVID-19 pandemic had a significant impact on people’s immune response to microorganisms. During the lockdown, inflammation level in the body was low, but afterwards, the immune system reacted more intensely to viruses and bacteria.
-
NewsSyphilis had its roots in the Americas, archaeological bone reveals
New research supports a root in the Americas for syphilis and its known relatives, and their introduction to Europe starting in the late 15th century is most consistent with the data, scientists say.
-
NewsCheese starter cultures yield insights into history of domestication of bacteria
A new study shows that the bacteria used to produce Gruyère, Emmental and Sbrinz cheese show signs of ancient domestication.
-
NewsStart-up EBViously announces its launch
EBViously, a spin-off of Helmholtz Munich, officially started operations on 11 November 2024. The company is developing a preventive vaccine against diseases caused by the Epstein-Barr virus (EBV).
-
NewsPediatric investigation study confirms the safety of COVID-19 vaccination during pregnancy
A new study shows that maternal COVID-19 vaccination is not associated with adverse health outcomes in infants.
-
NewsScientists find a vulnerability in antibiotic resistance mechanism
Superbugs, bacteria that are immune to multiple antibiotics, pose a great challenge to modern medicine. Researchers from the B CUBE - Center for Molecular Bioengineering at TUD Dresden University of Technology and Institut Pasteur in Paris identified a weakness in the bacterial machinery that drives antibiotic resistance adaptation. Their findings, ...
-
NewsGenome researchers unfurl protective mantle of influenza virus
The structure of the flu virus’s protective mantle and its interactions with its RNA have been described on an atomic scale by a research team for the first time.
-
NewsBreakthrough infection test designed to tackle AMR on target for 2025 UK NHS availability after positive trial results
UK medtech company Presymptom Health has announced positive results from its clinical trial of diagnostic technology in the management of infection and sepsis in patients presenting to Emergency Departments with respiratory infection.
-
NewsPatients whose allergies cause the sniffles have different fungi living in their noses, compared to healthy people
Scientists investigated the noses of people with asthma and allergic rhinitis and found that the fungi in their noses are different to healthy people, suggesting future targets for treatments.
-
OpinionSharing microbial sequence-based data: The way forward
Public sector data associated with health are a highly valuable resource, yet in practice data-sharing poses multiple challenges. Dr Nicola Holden, from AMI’s One Health Scientific Advisory Group, explores the murky morass of big data.
-
NewsDisney princesses face hidden health risks, including zoonotic infections, warn experts
Although Disney princesses seem to live happily ever after, they face serious real world health hazards, warn experts in the Christmas edition of the BMJ.
-
NewsDeadly mould strains highly likely to acquire resistance to new drugs
Scientists have identified strains of one of the world’s most dangerous fungal pathogens, already resistant to our most effective antifungal drugs, which are also five times more likely to acquire resistance to desperately needed new treatments in development. Source: Ufficio Comunicazione, Azienda Ospedaliera SS. Antonio e ...
-
NewsRoyal Veterinary College awarded international grants to advance research into cattle vaccines
The Royal Veterinary College (RVC) has been awarded two pump-prime grants from the International Veterinary Vaccinology Network (IVVN) to advance crucial research into Bovine Babesiosis and Bovine Tuberculosis vaccines to support cattle welfare.
-
NewsFrom Yemen to Mayotte, the spread of a highly drug-resistant cholera strain
Scientists have revealed the spread of a highly drug-resistant cholera strain. The strain is resistant to ten antibiotics – including azithromycin and ciprofloxacin, two of the three recommended for treating cholera – and was identified for the first time in Yemen in 2018-2019.
-
NewsNew guidelines unveil advanced strategies for HIV treatment and prevention
The International Antiviral (formerly AIDS) Society-USA (IAS-USA) has published new international guidelines for the treatment and prevention of HIV, based on significant advances in antiretroviral therapies and new prevention strategies such as pre-exposure prophylaxis.
-
NewsDiverse phage populations coexist on single strains of gut bacteria
A new study shows that a single bacterial species, the host of a phage, can maintain a diverse community of competing phage species. Several phage species coexist stably on a population of a genetically uniform strain of E. coli.
